Mechanisms involved in inhibition of chondrogenesis by activin-A

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 380-384

  Mitsugi, Sho ^a   Ariyoshi, Wataru ^a   Okinaga, Toshinori ^a   Kaneuji, Takeshi ^a   Kataoka, Yoshihiro ^a   Takahashi, Tetsu ^a   Nishihara, Tatsuji ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Activin A; Akt; Chondrocyte; JNK; Smad

Indexed keywords

ACTIVIN A; ALCIAN BLUE; GLYCOSAMINOGLYCAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; INHIBITION KINETICS; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SULFATION; WESTERN BLOTTING;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; MICE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84862788113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.003     Document Type: Article

References (36)

1. Knonenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
2. Kawaguchi H. Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol. Cells 2008, 25:1-6.
3. Lefebvre V., Huang W., Harley V.R., et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha (II) collagen gene. Mol. Cell Biol. 1997, 17:2336-2346.
4. Lefebvre V., Li P., de Crombrugghe B.A. B, A new bone form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. Embo J. 1998, 17:5718-5733.
5. Foster J.W., Dominguez-Steglich M.A., Guioli S., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-530.
6. Wagner T., Wirth J., Meyer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRYrelated gene SOX9. Cell 1994, 79:1111-1120.
7. Bi W., Deng J.M., Zhang Z., Behringer R.R., et al. Sox9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
8. Bi W., Deng J.M., Zhang Z., et al. Sox9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
9. Akiyama H., Chaboissier M.C., Martin J.F., et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required forexpression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
10. Shi Y., Massague J. Mechanisms of TGF-β signaling from cell membrane to nucleus. Cell 2003, 113:685-700.
11. Chen Y.G., Wnag Q., Lin S.L., et al. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp. Biol. Med. 2006, 231:534-544.
12. Ogawa Y., Schmidt D.K., Nathan R.M., et al. Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J. Biol. Chem. 1992, 267:14233-14237.
13. Ikenoue T., Jingushi S., Urabe K., et al. Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J. Cell Biochem. 1999, 75:206-214.
14. Gaddy-Kurten D., Coker J.K., Abe E., et al. Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 2002, 143:74-83.
15. Eijken M., Swagemakers S., Koedam M., et al. The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J. 2007, 11:2949-2960.
16. Fuller K., Bayley K.E., Chambers T.J. Activin-A is and essential cofactor for osteoclast induction. Biochem. Biophys. Res. Commun. 2000, 268:2-7.
17. Oue Y., Kanatani H., Kiyoki M., et al. Effect of local injection of activin A on bone formation in newborn rats. Bone 1994, 15:361-366.
18. Perrien D.S., Akel N.S., Edwards P.K., et al. Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 2007, 148:1654-1665.
19. Bonewald L.F., Mundy G.R. Role of transforming growth factor-beta in bone remodeling. Clin. Orthp. Relat. Res. 1990, 250:261-276.
20. Atsumi T., Miwa Y., Kimata K., et al. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell. Diff. Dev. 1990, 30:109-116.
21. Shukunami C., Ishizeki K., Atusmi T., et al. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 1997, 12:1174-1188.
22. Yamashita S., Andoh M., Ueno-Kudoh H., et al. Sox-9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp. Cell Res. 2009, 315:2231-2240.
23. Akiyama H., Hiraki Y., Shigeno C., et al. 1α, 25-dihydroxyvitamin D3 inhibits cell growth and chondrogenesis of a clonal mouse EC cell line, ATDC5. J. Bone Miner. Res. 1996, 11:22-28.
24. Shukunami C., Shigeno C., Atumi T., et al. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 1996, 133:457-468.
25. Chen P., Yu Y.M., Reddim A.H. Chondrogenesis in chick limb bud mesodermal cells: reciprocal modulation by activin and inhibin. Exp. Cell. Res. 1993, 206:119-127.
26. 1, and activin-A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp. Cell Res. 1994, 210:224-229.
27. Hartsough M.T., Frey R.S., Zipfel P.A., et al. Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. J. Biol. Chem. 1996, 37:22368-22375.
28. Frey R.S., Mulder K.M. Involvement of extraxwllular signal-related kinase 2 and stress-activated protein kinase/Jin N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res. 1997, 57:628-633.
29. Zabin M.K., Bundy J., Ernst H., et al. Distinct spatial and temporal distributions of aggrecan and versican in the embryonic chick heart. Anat. Rec. 1999, 256:366-380.
30. Yamaguchi K., Shirakabe K., Shibuya H., et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995, 270:2008-2011.
31. Hanafusa H., Ninomiya-Tsuji J., Masuyama N., et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta0induced gene expression. J. Biol. Chem. 1999, 274:27161-27167.
32. Boos N., Nerlich A.G., Wiest I., et al. Immunohistochemical analysis of type-X-collagen expression in osteoarthritis of the hip joint. J. Orthop. Res. 1999, 17:495-502.
33. Kamemura S., Kawasaki Y., Hoshi K., et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 2006, 54:2462-2470.
34. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
35. R. Monemdjou, F. Vasheghani, H. Fahmi, et al., Cartilage-specific deletion of PPARγ results in abnormal endochondral ossification, and cartilage growth and development, Arthritis Rheum., in press.
36. Dragovic J., Logar D.B., Komadina R., et al. Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue. Arc. Med. Res. 2011, 42:392-397.